ARGOS THERAPEUTICS INC 4
4 · ARGOS THERAPEUTICS INC · Filed Jan 23, 2017
Insider Transaction Report
Form 4
Harrelson Lori R.
Vice President of Finance
Transactions
- Award
Common Stock
2017-01-20+3,694→ 33,699 total - Award
Stock Option (right to buy)
2017-01-20+50,000→ 50,000 totalExercise: $5.05Exp: 2027-01-19→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 20, 2017 and vests as to 25% of the shares underlying this option on January 1, 2018, with the remaining 75% of the shares underlying this option vesting in equal amounts monthly over the next three years beginning January 1, 2018.